$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl

$kavl Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000173112222001542 Filed on September 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$3.847M	$3.060M	$2.842M
YoY Change	11.74%	-83.14%	-92.39%
Cost Of Revenue	$3.405M	$2.672M	$3.533M
YoY Change	-3.46%	-77.47%	-89.15%
Gross Profit	$442.1K	$387.7K	-$690.9K
YoY Change	-624.46%	-93.83%	-114.39%
Gross Profit Margin	11.49%	12.67%	-24.31%
Selling, General & Admin	$4.299M	$5.406M	$2.091M
YoY Change	28.21%	-47.82%	-52.26%
% of Gross Profit	972.49%	1394.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change
% of Gross Profit
Operating Expenses	$4.299M	$5.406M	$2.091M
YoY Change	28.21%	-47.82%	-52.15%
Operating Profit	-$3.857M	-$5.018M	-$2.782M
YoY Change	12.21%	23.22%	-746.97%
Interest Expense	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$3.857M	-$5.018M	-$2.782M
YoY Change	12.21%	23.23%	-762.37%
Income Tax		-$5.810K	$0.00
% Of Pretax Income
Net Earnings	-$3.857M	-$5.012M	-$2.782M
YoY Change	12.22%	17.69%	-997.41%
Net Earnings / Revenue	-100.25%	-163.8%	-97.89%
Basic Earnings Per Share	-$0.09
Diluted Earnings Per Share	-$92.95K	-$163.3K	-$92.01K
COMMON SHARES
Basic Shares Outstanding	56.17M shares
Diluted Shares Outstanding	41.49M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.358M	$4.662M	$5.590M
YoY Change	257.84%	117.76%	185.23%
Cash & Equivalents	$3.358M	$4.727M	$5.656M
Short-Term Investments
Other Short-Term Assets	$463.3K	$441.4K	$355.5K
YoY Change	102.16%	1371.43%
Inventory	$5.849M	$9.214M	$14.77M
Prepaid Expenses	$463.3K
Receivables	$1.448M	$1.176M	$1.296M
Other Receivables	$1.754M	$1.754M	$1.754M
Total Short-Term Assets	$12.87M	$17.25M	$23.76M
YoY Change	-46.0%	-64.88%	62.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.245M	$48.30K	$51.96K
YoY Change	2002.06%	-23.19%	-25.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.245M	$48.29K	$51.95K
YoY Change	2002.42%	-23.2%	-13.42%
TOTAL ASSETS
Total Short-Term Assets	$12.87M	$17.25M	$23.76M
Total Long-Term Assets	$1.245M	$48.29K	$51.95K
Total Assets	$14.12M	$17.29M	$23.81M
YoY Change	-40.92%	-64.82%	61.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$153.3K	$3.620M	$9.310M
YoY Change	-99.1%	-90.54%	48.96%
Accrued Expenses	$544.7K	$480.8K	$387.8K
YoY Change	42.99%	-70.18%	-66.86%
Deferred Revenue	$143.6K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.793M	$4.103M	$9.845M
YoY Change	-89.74%	-89.71%	11.12%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.095M	$39.18K	$42.69K
YoY Change	2103.34%	-25.88%	-28.85%
Total Long-Term Liabilities	$1.095M	$39.18K	$42.69K
YoY Change	2103.34%	-25.88%	-28.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.793M	$4.103M	$9.845M
Total Long-Term Liabilities	$1.095M	$39.18K	$42.69K
Total Liabilities	$2.888M	$4.142M	$9.888M
YoY Change	-83.52%	-89.63%	10.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.91M
YoY Change
Common Stock	$6.612M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.23M	$13.15M	$13.93M
YoY Change
Total Liabilities & Shareholders Equity	$14.12M	$17.29M	$23.81M
YoY Change	-40.92%	-64.82%	61.78%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$3.857M	-$5.012M	-$2.782M
YoY Change	12.22%	17.69%	-997.41%
Depreciation, Depletion And Amortization			$0.00
YoY Change
Cash From Operating Activities	-$1.375M	-$2.471M	-$2.134M
YoY Change	27.45%	-1188.86%	-60.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$35.76K
YoY Change			19.2%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.700K	1.542M	-35.76K
YoY Change	-104.61%	-3314.11%	19.2%
NET CHANGE
Cash From Operating Activities	-1.375M	-2.471M	-2.134M
Cash From Investing Activities
Cash From Financing Activities	5.700K	1.542M	-35.76K
Net Change In Cash	-1.369M	-928.9K	-2.169M
YoY Change	13.86%	-619.07%	-60.27%
FREE CASH FLOW
Cash From Operating Activities	-$1.375M	-$2.471M	-$2.134M
Capital Expenditures
Free Cash Flow			-$2.134M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet		usd
	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001762239
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	kavl	Inventory Deposit Related Party InventoryDepositRelatedParty		usd
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent		usd
CY2022Q3	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent		usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	kavl	Converted Series Preferred Stock To Common Shares ConvertedSeriesPreferredStockToCommonShares		usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
	kavl	Increase Decrease In Inventory Deposit Related Party IncreaseDecreaseInInventoryDepositRelatedParty		usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable		usd
	kavl	Increase Decrease In Customer Refund Due IncreaseDecreaseInCustomerRefundDue		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	kavl	Conversion Of3m Shares Of Series Preferred Stock Into25m Shares Of Common Stock ConversionOf3mSharesOfSeriesPreferredStockInto25mSharesOfCommonStock		usd
	kavl	New Rou Leased Asset Recognized NewRouLeasedAssetRecognized		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-07-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-56016
	dei	Entity Registrant Name EntityRegistrantName	KAIVAL BRANDS INNOVATIONS GROUP, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-3492907
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4460 Old Dixie Highway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Grant
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32949
	dei	City Area Code CityAreaCode	(833)
	dei	Local Phone Number LocalPhoneNumber	452-4825
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	KAVL
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56169090	shares
CY2022Q3	us-gaap	Cash Cash	3358124	usd
CY2021Q4	us-gaap	Cash Cash	7760228	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	65007	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1448298	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1985186	usd
CY2021Q4	kavl	Inventory Deposit Related Party InventoryDepositRelatedParty	2925000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	5849310	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	15326370	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	463304	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	319531	usd
CY2022Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	1753594	usd
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	1753594	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	12872630	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	30134916	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1245474	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55604	usd
CY2022Q3	us-gaap	Assets Assets	14118104	usd
CY2021Q4	us-gaap	Assets Assets	30190520	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	153322	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	242829	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	790242	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	12667769	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	544748	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	579604	usd
CY2022Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	143620	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	161550	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13020	usd
CY2021Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	316800	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1793482	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13820022	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1094622	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46185	usd
CY2022Q3	us-gaap	Liabilities Liabilities	2888104	usd
CY2021Q4	us-gaap	Liabilities Liabilities	13866207	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	3000	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56169090	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56169090	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30195312	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30195312	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	56169	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	30195	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28085787	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21551959	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16911956	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5260841	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	11230000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16324313	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14118104	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30190520	usd
CY2022Q3	kavl	Revenue Revenue	3854012	usd
CY2021Q3	kavl	Revenue Revenue	3116507	usd
	kavl	Revenue Revenue	9788368	usd
	kavl	Revenue Revenue	59238561	usd
CY2022Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	29319	usd
CY2021Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	70600	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	60469	usd
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	132145	usd
CY2022Q3	kavl	Excise Tax On Products ExciseTaxOnProducts	36070	usd
CY2021Q3	kavl	Excise Tax On Products ExciseTaxOnProducts	-4313	usd
	kavl	Excise Tax On Products ExciseTaxOnProducts	99669	usd
	kavl	Excise Tax On Products ExciseTaxOnProducts	668687	usd
CY2022Q3	us-gaap	Revenues Revenues	3847261	usd
CY2021Q3	us-gaap	Revenues Revenues	3191420	usd
	us-gaap	Revenues Revenues	9749168	usd
	us-gaap	Revenues Revenues	58702019	usd
CY2022Q3	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	3365010	usd
CY2021Q3	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	3175440	usd
	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	9477060	usd
	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	47446894	usd
CY2022Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	40186	usd
CY2021Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	100270	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	133283	usd
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	256538	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	3405196	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	3275710	usd
	us-gaap	Cost Of Revenue CostOfRevenue	9610343	usd
	us-gaap	Cost Of Revenue CostOfRevenue	47703432	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	442065	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	-84290	usd
	us-gaap	Gross Profit GrossProfit	138825	usd
	us-gaap	Gross Profit GrossProfit	10998587	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	657561	usd
CY2021Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	710832	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2011131	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2472019	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3641495	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2642200	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9784616	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15618548	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4299056	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	3353032	usd
	us-gaap	Operating Expenses OperatingExpenses	11795747	usd
	us-gaap	Operating Expenses OperatingExpenses	18090567	usd
CY2021Q3	us-gaap	Investment Income Net InvestmentIncomeNet	16	usd
	us-gaap	Investment Income Net InvestmentIncomeNet	392	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	392	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3856991	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3437306	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11656922	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7091588	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-300	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5807	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	292844	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3856991	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3437006	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11651115	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7384432	usd
CY2022Q3	kavl	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.09
CY2021Q3	kavl	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.15
	kavl	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.34
	kavl	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.32
CY2022Q3	kavl	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	41493644	shares
CY2021Q3	kavl	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	23603306	shares
	kavl	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	34259009	shares
	kavl	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	23380268	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16324313	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	110250	usd
CY2022Q1	kavl	Common Shares Settled And Cancelled CommonSharesSettledAndCancelled	-35759	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	309700	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2781964	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13926540	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	62006	usd
CY2022Q2	kavl	Common Shares Settled And Cancelled CommonSharesSettledAndCancelled	-24058	usd
CY2022Q2	kavl	Stock Issued For Services Restricted Common Shares StockIssuedForServicesRestrictedCommonShares	18160	usd
CY2022Q2	kavl	Exercise Of Common Stock Warrants ExerciseOfCommonStockWarrants	1566190	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	2616192	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-5012160	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	13152870	usd
CY2022Q3	kavl	Exercise Of Common Stock Warrants ExerciseOfCommonStockWarrants	5700	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1928421	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-3856991	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	11230000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	4417608	usd
CY2021Q1	kavl	Issuance Of Common Shares For Employee Compensation IssuanceOfCommonSharesForEmployeeCompensation	76700	usd
CY2021Q1	kavl	Common Shares Settled And Cancelled CommonSharesSettledAndCancelled	-30511	usd
CY2021Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1034596	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	311501	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	5809894	usd
CY2021Q2	kavl	Issuance Of Common Shares For Employee Compensation IssuanceOfCommonSharesForEmployeeCompensation	647461	usd
CY2021Q2	kavl	Common Shares Settled And Cancelled CommonSharesSettledAndCancelled	-47464	usd
CY2021Q2	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	6494555	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	579699	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-4258927	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	9225218	usd
CY2021Q3	kavl	Issuance Of Common Shares For Employee Compensation IssuanceOfCommonSharesForEmployeeCompensation	16534	usd
CY2021Q3	kavl	Common Shares Settled And Cancelled CommonSharesSettledAndCancelled	-123713	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	688511	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-3437006	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	6369544	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11651115	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7384432	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	190416	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8269846	usd
	kavl	Stock Option Plan Expenses StockOptionPlanExpenses	4854313	usd
	kavl	Stock Option Plan Expenses StockOptionPlanExpenses	1268210	usd
	kavl	Rou Operating Lease Expense RouOperatingLeaseExpense	86385	usd
	kavl	Rou Operating Lease Expense RouOperatingLeaseExpense	10887	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-536888	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6322852	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-15360	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	143773	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	229167	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9477060	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14940817	usd
	kavl	Increase Decrease In Inventory Deposit Related Party IncreaseDecreaseInInventoryDepositRelatedParty	2925000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-89507	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	284303	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-11877527	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	15404401	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-34856	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-693818	usd
	kavl	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	143620	usd
	kavl	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-623096	usd
	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-1331856	usd
	kavl	Increase Decrease In Customer Refund Due IncreaseDecreaseInCustomerRefundDue	316800	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-79288	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8547	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5979184	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6281578	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1571890	usd
	kavl	Settled Rsus With Cash SettledRsusWithCash	59817	usd
	kavl	Settled Rsus With Cash SettledRsusWithCash	201688	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1512073	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-201685	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4467111	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-6483266	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7825235	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7421701	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3358124	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	938435	usd
	kavl	Conversion Of3m Shares Of Series Preferred Stock Into25m Shares Of Common Stock ConversionOf3mSharesOfSeriesPreferredStockInto25mSharesOfCommonStock	25000	usd
	kavl	New Rou Leased Asset Recognized NewRouLeasedAssetRecognized	1276255	usd
CY2021Q3	kavl	Common Stock Par Or Stated Values Per Share CommonStockParOrStatedValuesPerShare	0.001
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7825235	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zJaTXFHDMBI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86E_zVOmJcEmgu15">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3358124	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7825235	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	65007	usd
CY2022Q3	us-gaap	Cash Cash	3358124	usd
CY2021Q4	us-gaap	Cash Cash	7760228	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	65007	usd
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3358124	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2021Q4	kavl	Consignment Agreement Amount ConsignmentAgreementAmount	2556930	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	143620	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022Q3	kavl	Refunds Due Amounts RefundsDueAmounts	0	usd
CY2021Q4	kavl	Refunds Due Amounts RefundsDueAmounts	316800	usd
	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	3628691	usd
	kavl	Revenue From Sale RevenueFromSale	1399106	usd
	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	18435648	usd
	kavl	Revenue From Sale RevenueFromSale	9598426	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6555828	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
	kavl	Reverse Stock Split Description ReverseStockSplitDescription	as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock.
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P10Y
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P10Y
CY2022Q3	kavl	Stock Option Plan Expenses StockOptionPlanExpenses	1928421	usd
	kavl	Stock Option Plan Expenses StockOptionPlanExpenses	4854313	usd
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	3000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-12
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56169090	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56169090	shares
CY2022Q2	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1245474	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55604	usd
	kavl	Recognition Of Rou Operating Lease RecognitionOfRouOperatingLease	1276300	usd
CY2022Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2021	kavl	Recognition Of Rou Liability RecognitionOfRouLiability	14529	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	86385	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13020	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46185	usd
CY2021Q4	kavl	Operating Leases Liability OperatingLeasesLiability	59205	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	161550	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1094622	usd
CY2022Q3	kavl	Lease Liability LeaseLiability	1256172	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	53330	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	217467	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	228134	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	238800	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	253614	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	450935	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1442280	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	186108	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1256172	usd
CY2022Q3	kavl	Operating Leases Liability Current OperatingLeasesLiabilityCurrent	161550	usd
CY2022Q3	kavl	Operating Leases Liability Noncurrent OperatingLeasesLiabilityNoncurrent	1094622	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	4854313	usd
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30195312	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30195312	shares
CY2022Q3	kavl	Common Stock Shares Issueds CommonStockSharesIssueds	18160	shares
CY2021Q3	kavl	Issuance Of Warrants IssuanceOfWarrants	4053750	shares
CY2021Q4	kavl	Exercise Price Per Share ExercisePricePerShare	1.90
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2021Q4	kavl	Restricted Stock Unit Awards Description RestrictedStockUnitAwardsDescription	the Company issued 61,250 shares of Common Stock to 7 employees in accordance with the vesting schedules set forth in restricted stock unit (“RSU”) agreements previously entered into with such employees, resulting in the recognition of approximately $110,250 of share-based compensation. Of the shares issued to employees, 19,866 shares were withheld by the Company to satisfy tax withholding obligations and/or satisfy cash settlement options to employees, equaling approximately $35,759.
CY2022Q1	kavl	Restricted Stock Unit Awards Description RestrictedStockUnitAwardsDescription	the Company issued 62,006 shares of Common Stock to 7 employees in accordance with the vesting schedules set forth in RSU agreements previously entered into with such employees, resulting in the recognition of $62,006 of share-based compensation. Of the shares issued to employees, 24,058 shares were withheld by the Company to satisfy tax withholding obligations and/or satisfy cash settlement options to employees, equaling approximately $24,058. On March 4, 2022, the Company’s Board approved the termination of the RSU agreements with the consent of the employees. At the time these agreements were terminated, there remained 1,564,166 unvested RSUs with approximately $4,457,875 of related unvested compensation.
CY2021	kavl	Stock Option Awards Description StockOptionAwardsDescription	the Company granted options exercisable for up to 150,000 shares of Common Stock of which 15,000 fully vested on March 17, 2021, 7,500 fully vested on June 30, 2021, 41,667 fully vested on December 1, 2021, 17,500 vested on March 17, 2022, 8,750 vest on June 30, 2022 and 1,248 vest over the next year on March 17, 2023 and June 30, 2023. The options have exercise prices ranging from $9.12 to $28.68 per share. On July 19, 2021, two of the stock option agreements, exercisable for an aggregate of 50,000 shares of Common Stock, were modified to accelerate the full vesting period from 3 years to 2 years. On June 24, 2022, 33,333 of the stock options reference above were canceled and a further 25,002 were cancelled in the current quarter.
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	200000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.9493	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	75000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	500000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3948948	shares
CY2022Q3	us-gaap	Share Price SharePrice	2.85
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.9455	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0162	pure
	kavl	Unamortized Stock Option Expense UnamortizedStockOptionExpense	1151771	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y5M4D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y9M10D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2021Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	680	usd
	kavl	Inventory Quality Control Expenses InventoryQualityControlExpenses	654500	usd
CY2022Q3	us-gaap	Accrued Rent Current AccruedRentCurrent	23367	usd
	kavl	Bonus Description BonusDescription	cash bonus award equal to $30,000 for every $25 million in gross revenues generated by the Company. With respect to the Chief Operating Officer, the Board approved a cash bonus award equal to $20,000 for every $25 million in gross revenues generated by the Company. On May 28, 2020, the Board also approved an equity bonus award for each of the Chief Executive Officer and the Chief Operating Officer. With respect to the Chief Executive Officer, the Board approved an award of 7,500 restricted shares of the Common Stock for every $50 million in accumulated gross revenues generated by the Company. With respect to the Chief Operating Officer, the Board approved an award of 6,250 restricted shares of the Common Stock for every $50 million in accumulated gross revenues generated by the Company. The Company’s accumulated gross revenues will be evaluated on a quarterly basis, beginning with the second quarter of fiscal year 2020. At October 31, 2020, the Company determined that the fair value of the equity bonus shares, or $165,000, should be accrued as it was deemed likely that the $50 million revenue target would be met. The Company issued these shares to the Chief Executive Officer and Chief Operating Office on January 1, 2021. During the quarter ended April 30, 2021, the $75 million and $100 million accumulated revenue targets were both achieved and the Company determined that the fair market value of the 13,750 shares, or approximately $70,785, and the cash bonuses totaling $100,000 should be accrued at April 30, 2021.
CY2022Q2	us-gaap	Deferred Revenue Leases Accumulated Amortization DeferredRevenueLeasesAccumulatedAmortization	125000000	usd
CY2022Q2	kavl	Cash Bonuses CashBonuses	50000	usd
	kavl	General Compensation Description GeneralCompensationDescription	the Company paid QuikfillRx an amount equal to $86,000; (ii) for the Services provided in April 2020, the Company paid QuikfillRx an amount equal to $100,000; (iii) each calendar month commencing May 2020 through October 2020, the Company paid QuikfillRx an amount equal to $125,000 per month for the Services to be performed during such calendar month; (iv) for each calendar month between November 1, 2020 and October 31, 2021, the Company paid QuikfillRx $125,000 per month for the Services to be performed during such calendar month; (iv) for the period between November 1, 2021 and June 30, 2022, the Company paid QuikfillRx $150,000 per month for the Services to be performed during such calendar month; (v) for the period between July 1, 2022 and October 31, 2024, the Company will pay QuikfillRx $125,000 per month for the Services to be performed during such calendar month; and (vi) parties acknowledged that as a result of extensions to the term of the Service Agreement , such term of the Original Agreement will end on October 31, 2023.
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.03
CY2022Q3	kavl	Stock Option Expense StockOptionExpense	193500	usd
	kavl	Acquired Quqrterly Bonus AcquiredQuqrterlyBonus	45013	usd

Files In Submission

Name	View Source	Status
0001731122-22-001542-index-headers.html	Edgar Link	pending
0001731122-22-001542-index.html	Edgar Link	pending
0001731122-22-001542.txt	Edgar Link	pending
0001731122-22-001542-xbrl.zip	Edgar Link	pending
e4045_10-q.htm	Edgar Link	pending
e4045_ex31-1.htm	Edgar Link	pending
e4045_ex31-2.htm	Edgar Link	pending
e4045_ex32-1.htm	Edgar Link	pending
e4045_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kavl-20220731.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kavl-20220731_def.xml	Edgar Link	unprocessable
kavl-20220731_cal.xml	Edgar Link	unprocessable
kavl-20220731_pre.xml	Edgar Link	unprocessable
e4045_10-q_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
kavl-20220731_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl

2022 Q3 Form 10-Q Financial Statement

#000173112222001542 Filed on September 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAVL Kaival Brands Innovations Group, Inc. Stock $kavl

2022 Q3 Form 10-Q Financial Statement

#000173112222001542 Filed on September 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl